Company profile: Incline Therapeutics
1.1 - Company Overview
Company description
- Provider of hospital-focused specialty pharmaceutical solutions, developing IONSYS (fentanyl iontophoretic transdermal system), a pharmaceutical device for the treatment of post-operative pain in hospital settings.
Products and services
- Fentanyl Iontophoretic Transdermal System Development: Incline Therapeutics architects specialty-pharmaceutical development of the fentanyl iontophoretic transdermal system for treating post-operative pain in hospital settings, led by management with significant pharmaceutical and medical device industry experience
- Hospital-Focused Specialty Pharmaceutical Development: Incline Therapeutics delivers hospital-focused development centered on IONSYS, a fentanyl iontophoretic transdermal system for treating post-operative pain in hospitals, supported by leading life science venture capital financing
- IONSYS: Incline Therapeutics engineers an iontophoretic fentanyl transdermal device that treats post-operative pain in hospital settings by delivering fentanyl through a transdermal iontophoretic mechanism
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Incline Therapeutics
Nutriband
HQ: United States
Website
- Description: Provider of abuse-deterrent transdermal technologies and drug delivery systems, including the AVERSA platform integrating abuse-deterrent features into patches for fentanyl, buprenorphine, and methylphenidate, and 4P transdermal systems delivering Exenatide for Type 2 Diabetes and FSH for infertility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutriband company profile →
Medical International Technology
HQ: Canada
Website
- Description: Provider of needle-free jet injectors for human and animal vaccinations, developing, marketing, and distributing these devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical International Technology company profile →
Flowonix Medical
HQ: United States
Website
- Description: Provider of medical device solutions for patients with chronic disorders, featuring the Prometra Programmable Infusion Pump System, an implantable intrathecal drug delivery system indicated for use with specific medications to treat chronic pain and spasticity in adults and adolescents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flowonix Medical company profile →
Elektrofi
HQ: United States
Website
- Description: Provider of a microparticle platform (Hypercon) enabling low-volume, stable, hyper-concentrated biologic formulations for subcutaneous delivery, alongside formulation development services—covering process development, formulation, analytics, and innovation—and partnership programs with pharmaceutical companies to develop and commercialize subcutaneous biologic therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elektrofi company profile →
Travanti Pharma
HQ: United States
Website
- Description: Provider of innovative drug delivery platforms that improve the safety, compliance, effectiveness, and ease of administration of medications delivered into the body; designs, develops, and markets these platforms to enhance medication delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Travanti Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Incline Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Incline Therapeutics
2.2 - Growth funds investing in similar companies to Incline Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Incline Therapeutics
4.2 - Public trading comparable groups for Incline Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →